SEC Form 4 · accession 0001179110-16-017593
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip R Jacoby Jr.
Officer — Principal Accounting Officer
Period of report
Jan 8, 2016
Accepted (ET)
Jan 8, 2016 · 8:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $5.08 | Jan 8, 2016 | D | 5,000 | D | Mar 23, 2016 | Oct 21, 2016 | Common Stock | 5,000 | 54,181 | D |
| Incentive Stock Option (right to buy)F1 | $7.73 | Jan 8, 2016 | D | 10,000 | D | Feb 12, 2016 | Oct 21, 2016 | Common Stock | 10,000 | 44,181 | D |
Explanation of responses
- F1Unvested incentive stock options that were forfeited concurrent with the Reporting Person's retirement from employment with the Registrant, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan. The Reporting Person's stock options that were vested on the date that he was determined to be medically disabled will remain exercisable for twelve months from the date of disability.